Chargement en cours...
Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: A phase II open label clinical trial
Neuroinflammation through the cytokine, tumor necrosis factor-alpha (TNF-α) is thought to play an important role in the pathogenesis of amyotrophic lateral sclerosis (ALS). We conducted a preliminary phase II trial of thalidomide, which reduces levels of TNF-α pre-transcriptionally and post-transcri...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3820489/ https://ncbi.nlm.nih.gov/pubmed/19922130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/17482960802709416 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|